PALB2 and pancreatic neoplasm: PALB2 somatic PV occur in both pancreatic cancer and prostate cancer samples, whereas germline PV have been described in pancreatic cancer patients, at a slightly higher rate in high-risk compared to apparently sporadic patients (0.97% and 0.1–0.65%, respectively) [35,59].